Although previous reports have indicated that xCT depletion in tumor cells leads to impaired tumor growth in vivo [18], our data obtained in mammary cancer-prone BALB-neuT mice show that congenital, total body xCT deficiency does not affect the time of onset or the multiplicity of tumors, but reduces the incidence of lung metastases. Here, SLC7A11 is linked to neoplasm.